I am a woman in pediatric rheumatology. Even in a predominantly female field, at times I feel compelled to mask my emotional response to the consistently complicated, often overwhelming and sometimes ambiguous nature of the job. Rather than detach, however, I choose to emotionally engage with the medical experience through my own medicine: narratives.
Dr. John Cush RheumNow
3 years 6 months ago
A Danish national registry study compared RA pts taking JAKi (n 875) and bDMARDs (n 4247). They found similar rates of subsequent cancers (14.4 vs 12.9/ per 1000 PYRS); with a nonsignificant risk (HR1.41; CI 0.76, 2.37) https://t.co/ePuCiLvDmk https://t.co/caj6PVRHpw
The British Medical Journal has publish a matched cohort analysis demonstrating that adults receiving denosumab had a lower risk of incident type 2 diabetes (NIDDM) compared with those taking oral bisphosphonates for osteoporosis.
Design Population based study involving emulation of a randomized target trial using electronic health records.
Dr. John Cush RheumNow
3 years 6 months ago
Dr. Jeff Sparks talks sex differences and rheumatoid arthritis associated interstitial lung disease.
https://t.co/asUrfXw2Y1 https://t.co/oLwi8BvquO
Dr. John Cush RheumNow
3 years 6 months ago
Brazil study of 1,528 kid lupus (cSLE) shows low mortality (4.1%, n=63); 84%F, age 12 yrs w/ time to death=3.2yrs post-Dx. Cause?1) Sepsis (43%), 2) opportunistic infx(11%), & 3) Pulm hemorrhage (9.5%). Predictors: CNS lupus (HR 2.6) & CKD (HR 4.3) https://t.co/mocrJ2b8Mz https://t.co/TdJ7tFYr1r
Dr. John Cush RheumNow
3 years 6 months ago
RheumThoughts: My Life in the Gray Zone
Dr. Kathryn Dao ( @KDAO2011 ) shares how she lives in this gray zone and not get frustrated.
https://t.co/B1cZArBbpG https://t.co/l9ge0K05NX
Why does the Association of Women in Rheumatology (AWIR, pronounced AWARE) exist? Recalling a singular event several years ago prompted the action of four women to rectify the issue we were witnessing. Rheumatologists are increasingly female, and yet the leadership roles are still male dominant. Empowering females to amplify their own voices became our mantra and call to action.
Dr. John Cush RheumNow
3 years 6 months ago
Finnish population study involving 4180 #JIA patients followed for 6+ years (betw mean ages of 8.3 to 14.8 years), finds that 13% of the JIA patients prescribed psychotropic drugs (vs 10% in controls; p<0.001). Antidepressant use most freq, esp in females https://t.co/PcFhGz291J https://t.co/Ss9NzgC8vp
Two independent data sets suggests the prevalence of gout among Asians has grown such that this sub-population has numerically surpassed all other racial and ethnic groups by 2018.
Dr. John Cush RheumNow
3 years 6 months ago
NY Times on Arthritis Prevention
A reader question ("Ask Well") to the New York times wonders "is arthritis avoidable"?
A recent survey suggests that up to 60% of adults have been told by an HCP they had some form of arthritis.
https://t.co/ORcbQHjgSk https://t.co/mw5YGYdgWx
Dr. John Cush RheumNow
3 years 6 months ago
New podcast available-- "Want to Go Far, Go Together "
https://t.co/DUwjKfXRDI https://t.co/08Y1IF9Vk3
Dr. John Cush RheumNow
3 years 6 months ago
Aging Mechanisms Tied to Giant Cell Arteritis
Senescence pathways are involved in GCA, an analysis of patient tissue samples suggested, which may account for the efficacy of one agent now used for the disease and another in commercial development.
https://t.co/H2nzmQkSst https://t.co/JE7h9ihJUx
Dr. John Cush RheumNow
3 years 6 months ago
The Power of Collaboration: Building Relationships to Amplify Your Impact and Have More Fun
Collaboration has proven to be an essential ingredient for progress and innovation in rheumatology.
https://t.co/PIcpNsSseX https://t.co/ihatBPO4Oy
When I was accepted into medical school, my Dad (a trauma surgeon) taught me that as a doctor I should not judge and do my best not to let my personal views interfere with how I manage and interact with my patients.
Dr. Yvonne Sherrer and second-year fellow Dr. Corin Agoris discuss a case where extended time led to improved patient outcomes.



